Arbor Biotechnologies

Arbor Biotechnologies, located in Cambridge, Massachusetts, is an early-stage life sciences company discovering and developing the next generation of genetic medicines. Arbor uses its proprietary discovery engine to uncover unique and wholly-owned CRISPR-based genetic modifiers with differentiated genetic editing capabilities.